Technical analysis of Sanofi (SNY): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare.
Price Performance
| 1 month | +11.07% |
| 3 months | +3.89% |
| Year-to-date | -8.50% |
| 1 year | -12.34% |
| 3 years | -3.19% |
| 5 years | -15.30% |
| 10 years | +11.02% |
52-Week Range
| 52-week High | $52.68 |
| 52-week Low | $39.07 |
| Avg Volume (90d) | 3.2M |
Technical Indicators
| SMA 50 | $42.21 |
| SMA 200 | $44.33 |
| Beta | 0.32 |
| 30-day Volatility (annualised) | 25.0% |
| Price vs SMA 50 | +5.1% |
| Price vs SMA 200 | +0.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $48.46 | |
| 2026-01 | $47.04 | -2.9% |
| 2026-02 | $48.66 | +3.4% |
| 2026-03 | $48.18 | -1.0% |
| 2026-04 | $46.58 | -3.3% |
| 2026-05 | $43.67 | -6.2% |
| 2026-06 | $42.66 | -2.3% |
| 2026-07 | $43.08 | +1.0% |
| 2026-08 | $44.36 | +3.0% |
| 2026-09 | $41.23 | -7.1% |
| 2026-10 | $44.34 | +7.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-04 | $1.07 | $14.38B |
| 2026-10-30 | $1.56 | $14.29B |
| 2026-07-30 | $1.10 | $15.34B |
| 2026-04-23 | $1.06 | $12.68B |
| 2026-01-29 | $0.84 | $11.71B |
| 2025-10-24 | $1.60 | $11.11B |
| 2025-07-31 | $0.96 | $12.36B |
Price
| Price | $45.55 (closing price, November 2, 2026) |
| Market Cap | $109.8B |
| Exchange | NASDAQ |
| Country | FR |
Valuation Ratios
| P/E Ratio | 25.05 |
| Price / Book | 1.42 |
| Dividend Yield | 10.17% |
Financial Health
| Debt / Equity | 0.34 |
| Current Ratio | 0.99 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.74 |